2016 Q4 Form 10-K Financial Statement

#000156459017005738 Filed on March 31, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2016 Q2
Revenue $8.769M $9.405M $10.19M
YoY Change 5.83% 43.33% 43.77%
Cost Of Revenue $5.080M $6.163M -$250.0K
YoY Change -3.05% 74.84% -105.63%
Gross Profit -$2.300M $3.242M -$3.430M
YoY Change -175.41% 6.75% -229.43%
Gross Profit Margin -26.23% 34.47% -33.65%
Selling, General & Admin $8.210M $11.68M $7.390M
YoY Change -41.94% 37.2% -29.35%
% of Gross Profit 360.27%
Research & Development $6.360M $7.114M $7.580M
YoY Change -14.17% -7.75% -27.88%
% of Gross Profit 219.43%
Depreciation & Amortization $450.0K $2.370M $870.0K
YoY Change -44.44% 40.24% 20.83%
% of Gross Profit 73.1%
Operating Expenses $14.57M $18.79M $14.97M
YoY Change -32.39% 15.83% -28.58%
Operating Profit -$14.55M -$86.57M -$12.85M
YoY Change -21.34% 556.39% -29.85%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$390.0K -$493.0K -$4.000K
YoY Change 3800.0% -686.9% -80.0%
Pretax Income -$14.95M -$87.06M -$12.85M
YoY Change -19.25% 564.36% -29.89%
Income Tax -$1.100M -$15.32M -$11.00K
% Of Pretax Income
Net Earnings -$14.95M -$71.74M -$12.84M
YoY Change -16.49% 465.78% -27.53%
Net Earnings / Revenue -170.44% -762.8% -125.95%
Basic Earnings Per Share -$3.55
Diluted Earnings Per Share -$10.31M -$3.55 -$8.795M
COMMON SHARES
Basic Shares Outstanding 20.25M 20.24M
Diluted Shares Outstanding 20.24M

Balance Sheet

Concept 2016 Q4 2016 Q3 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.50M $60.70M $5.500M
YoY Change 1084.78%
Cash & Equivalents $9.676M $10.89M $5.496M
Short-Term Investments $44.80M $49.80M
Other Short-Term Assets $2.026M $4.200M $4.300M
YoY Change -11.91%
Inventory $6.639M $11.57M $20.10M
Prepaid Expenses
Receivables $4.284M $2.958M $8.500M
Other Receivables $0.00 $0.00 $1.400M
Total Short-Term Assets $71.41M $79.43M $39.80M
YoY Change 103.26%
LONG-TERM ASSETS
Property, Plant & Equipment $5.910M $6.139M $6.300M
YoY Change 41.42%
Goodwill $29.21M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.600M
YoY Change
Total Long-Term Assets $20.44M $21.19M $93.67M
YoY Change -77.93%
TOTAL ASSETS
Total Short-Term Assets $71.41M $79.43M $39.80M
Total Long-Term Assets $20.44M $21.19M $93.67M
Total Assets $91.86M $100.6M $133.5M
YoY Change -28.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.50M $9.000M $11.20M
YoY Change 3.96%
Accrued Expenses $4.000M $3.400M $2.700M
YoY Change 21.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $19.54M $15.23M $17.00M
YoY Change -2.0%
LONG-TERM LIABILITIES
Long-Term Debt $18.38M $18.11M $0.00
YoY Change
Other Long-Term Liabilities $469.0K $433.0K $3.400M
YoY Change 560.56%
Total Long-Term Liabilities $18.85M $18.54M $3.400M
YoY Change 26452.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.54M $15.23M $17.00M
Total Long-Term Liabilities $18.85M $18.54M $3.400M
Total Liabilities $41.29M $36.87M $36.27M
YoY Change 5.47%
SHAREHOLDERS EQUITY
Retained Earnings -$80.69M -$65.75M
YoY Change -65.22%
Common Stock $151.3M $149.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $50.57M $63.75M $97.20M
YoY Change
Total Liabilities & Shareholders Equity $91.86M $100.6M $118.2M
YoY Change -28.11%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2016 Q2
OPERATING ACTIVITIES
Net Income -$14.95M -$71.74M -$12.84M
YoY Change -16.49% 465.78% -27.53%
Depreciation, Depletion And Amortization $450.0K $2.370M $870.0K
YoY Change -44.44% 40.24% 20.83%
Cash From Operating Activities -$6.660M -$140.0K -$15.95M
YoY Change -13.28% -98.5% 0.95%
INVESTING ACTIVITIES
Capital Expenditures -$580.0K $50.00K -$910.0K
YoY Change 11.54% -111.36% 111.63%
Acquisitions
YoY Change
Other Investing Activities $4.920M -$49.80M
YoY Change
Cash From Investing Activities $4.350M -$49.76M -$910.0K
YoY Change -936.54% 11209.09% 111.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.110M 55.29M 19.28M
YoY Change -88.14% 499.67% 4.95%
NET CHANGE
Cash From Operating Activities -6.660M -140.0K -15.95M
Cash From Investing Activities 4.350M -49.76M -910.0K
Cash From Financing Activities 1.110M 55.29M 19.28M
Net Change In Cash -1.200M 5.390M 2.420M
YoY Change -203.45% -1029.31% 13.08%
FREE CASH FLOW
Cash From Operating Activities -$6.660M -$140.0K -$15.95M
Capital Expenditures -$580.0K $50.00K -$910.0K
Free Cash Flow -$6.080M -$190.0K -$15.04M
YoY Change -15.08% -97.87% -2.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6456000
CY2015Q4 us-gaap Inventory Net
InventoryNet
20322000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5910000
CY2016Q4 us-gaap Assets
Assets
91858000
CY2015Q4 us-gaap Assets
Assets
127767000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4009000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3334000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9676000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4284000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2512000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18383000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
469000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
71000
CY2016Q4 us-gaap Liabilities
Liabilities
41292000
CY2015Q4 us-gaap Liabilities
Liabilities
39149000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-231988000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
88618000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
127767000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1107000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4179000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19544000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
151271000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29518000
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20918290
CY2016Q2 dei Entity Public Float
EntityPublicFloat
30800000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4637000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
400000
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
44849000
CY2016Q4 us-gaap Inventory Net
InventoryNet
6639000
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1376000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5566000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2343000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
71414000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
35134000
CY2015Q4 apvo In Process Research And Development
InProcessResearchAndDevelopment
41800000
CY2016Q4 apvo Intangible Assets Net Excluding Goodwill And In Process Research And Development
IntangibleAssetsNetExcludingGoodwillAndInProcessResearchAndDevelopment
14534000
CY2015Q4 apvo Intangible Assets Net Excluding Goodwill And In Process Research And Development
IntangibleAssetsNetExcludingGoodwillAndInProcessResearchAndDevelopment
17441000
CY2015Q4 us-gaap Goodwill
Goodwill
29213000
CY2016Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
11489000
CY2015Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
10084000
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
444000
CY2016Q4 apvo Sales Rebates And Discounts
SalesRebatesAndDiscounts
3235000
CY2015Q4 apvo Sales Rebates And Discounts
SalesRebatesAndDiscounts
2238000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3843000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19943000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2896000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3318000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
15817000
CY2015Q4 apvo Former Parent Investment In Subsidiary
FormerParentInvestmentInSubsidiary
320606000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
24182000
CY2015 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2384000
CY2016 apvo Increase Decrease In Sales Rebates And Discounts
IncreaseDecreaseInSalesRebatesAndDiscounts
-997000
CY2015 apvo Increase Decrease In Sales Rebates And Discounts
IncreaseDecreaseInSalesRebatesAndDiscounts
8000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3454000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2620000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38666000
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
71013000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-810000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-237000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-127755000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-61337000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15340000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2020000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.55
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.93
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20239160
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20229849
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-33000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-112448000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59317000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3809000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3362000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2907000
CY2016 apvo Restricted Cash
RestrictedCash
400000
CY2016 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-15817000
CY2015 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1361000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200000
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3481000
CY2016 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-444000
CY2015 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
214000
CY2016 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
1376000
CY2015 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-66000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3223000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2860000
CY2016 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2479000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-36862000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-48760000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1527000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
44882000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1527000
CY2016 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
18000
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20000000
CY2016 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1962000
CY2016 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
71219000
CY2015 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
52220000
CY2015 apvo Contingent Consideration Payments
ContingentConsiderationPayments
889000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
89295000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
51331000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5039000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1044000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3593000
CY2016 us-gaap Interest Paid
InterestPaid
537000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
162000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
94608000
CY2015 apvo Stockholders Equity Net Transfers From Former Parent
StockholdersEquityNetTransfersFromFormerParent
53327000
CY2016 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
20000
CY2016 apvo Stockholders Equity Net Transfers From Former Parent
StockholdersEquityNetTransfersFromFormerParent
70529000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
18000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3809000
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p></div>
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Financial instruments that potentially subject Aptevo to concentrations of credit risk consist primarily of cash and cash equivalents, certain investments and accounts receivable. Aptevo places its cash and cash equivalents with high quality financial institutions and may maintain cash balances in excess of insured limits. Management believes that the financial risks associated with its cash and cash equivalents are minimal.</p></div>
CY2016 us-gaap Revenue Recognition Revenue Reductions
RevenueRecognitionRevenueReductions
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Sales Rebates and other Discounts</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Aptevo markets and sells its products through commercial wholesalers (direct customers) who purchase the products at a price referred to as the wholesale acquisition cost (WAC). Additionally, Aptevo may enter into separate agreements with indirect customers to acquire its products for a contracted price that is less than the product&#8217;s WAC. The indirect customers, such as group-purchasing organizations, physician practice-management groups and hospitals, continue to purchase Aptevo&#8217;s products from the wholesalers, but at their respective contractual prices. Per its wholesaler agreements, Aptevo guarantees to credit the wholesaler for the difference between the WAC and the indirect customers&#8217; contracted price. This credit is referred to as a chargeback and revenues from product sales are recorded net of estimated chargebacks. Adjustments to the chargeback provisions are made periodically to reflect new facts and circumstances, therefore historical experience may not be indicative of current and/or future results.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All revenues from product sales are also recorded net of applicable allowances for sales and government rebates, special promotional programs, and discounts. Management does not believe there to be a legal right of offset related to these allowances and the receivables from wholesalers; accordingly, allowances are classified as a current liability in the accompanying balance sheets These allowances are estimated based on historical payment experience, historical relationship to revenues, estimated customer inventory levels, contract terms, and actual discounts offered. In arriving at these estimates, Aptevo further utilizes information received from third parties including market data, inventory reports from major wholesalers, historical information and analysis. These estimates are subject to the inherent limitations of estimates that rely on third-party data, as certain third-party information may itself rely on estimates and reflect other limitations.</p></div>
CY2016 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Product Sales</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">The Company markets and sells its products through commercial wholesalers (direct customers) who purchase the products at a price referred to as the wholesale acquisition cost (WAC). Additionally, the Company may enter into separate agreements with indirect customers to acquire its products for a contracted price that is less than the product&#8217;s WAC. The indirect customers, such as group-purchasing organizations, physician practice-management groups and hospitals, continue to purchase the Company&#8217;s products from the wholesalers, but at their respective contractual prices. Per its wholesaler agreements, the Company guarantees to credit the wholesaler for the difference between the WAC and the indirect customers&#8217; contracted price. This credit is referred to as a chargeback and revenues from product sales are recorded net of estimated chargebacks. Adjustments to the chargeback provisions are made periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All revenues from product sales are also recorded net of applicable allowances for sales and government rebates, special promotional programs, and discounts. These allowances are estimated based on historical payment experience, historical relationship to revenues, estimated customer inventory levels, contract terms, and actual discounts offered. In arriving at these estimates, the Company further utilizes information received from third parties including market data, inventory reports from major wholesalers, historical information and analysis. These estimates are subject to the inherent limitations of estimates that rely on third-party data, as certain third-party information may itself rely on estimates and reflect other limitations. </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company defers the recognition of revenue from the sales of new product introductions until the commercial wholesalers resell the product to the healthcare providers. This is due to the inherent uncertainties in estimating normal wholesaler inventory levels of new products in addition to possible product launch incentives such as extended payment terms and expanded return rights that allow the wholesalers to return the product. Once the Company gains enough historical experience to reasonably estimate allowances for chargebacks, rebates and other discounts, revenue from sales and the related allowances are recognized upon sale to the wholesaler. </p></div>
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14534000
CY2016 apvo Date Of Spinoff
DateOfSpinoff
2016-08-01
CY2016Q3 apvo Noncash Transfer Of Intangible Asset
NoncashTransferOfIntangibleAsset
700000
CY2016Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
35000000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
3300000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
3500000
CY2016 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
50064000
CY2016Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2016Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2016 apvo Royalty Agreement Expiration Date
RoyaltyAgreementExpirationDate
2016-06-30
CY2016 apvo Future Royalty Payments Expected
FutureRoyaltyPaymentsExpected
0
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
444000
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
19000
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
463000
CY2016Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
260000
CY2015Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
6520000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1165000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4730000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5214000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9072000
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
7100000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12548000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10036000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6638000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5857000
CY2016Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
41800000
CY2016Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
29200000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2200000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000
CY2016 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P85M
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2083000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2083000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2083000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2083000
CY2016Q4 apvo Finite Lived Intangible Assets Amortization Expense Year Five And After
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter
6202000
CY2016 us-gaap Line Of Credit Facility Frequency Of Payment And Payment Terms
LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms
The loan repayment will include interest (no principal) through August 2018. Commencing in August 2018, the payments will include principal and interest and will be repaid in full on February 1, 2021 (54 months).
CY2016Q3 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P54M
CY2016Q3 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2021-02-01
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-14946000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-29000
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1357000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3050000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3910000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30392000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
132512000
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
13043000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-660000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-14630000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-681000
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1360000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15311000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1360000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
7237000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
90121000
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
575000
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
797000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
575000
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
13840000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29817000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
134489000
CY2016 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
LIBOR
CY2016Q3 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0760
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
384000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
13026000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3460000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
371000
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
17464000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1726000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1167000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
17755000
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1716000
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
160000
CY2016Q4 us-gaap Due From Other Related Parties
DueFromOtherRelatedParties
20000000
CY2016Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1900000
CY2016Q4 apvo Payment Of Principal And Interest On Debt In Next Twelve Months
PaymentOfPrincipalAndInterestOnDebtInNextTwelveMonths
1620000
CY2016Q4 apvo Payment Of Principal And Interest On Debt In Year Two
PaymentOfPrincipalAndInterestOnDebtInYearTwo
4908000
CY2016Q4 apvo Payment Of Principal And Interest On Debt In Year Three
PaymentOfPrincipalAndInterestOnDebtInYearThree
9053000
CY2016Q4 apvo Payment Of Principal And Interest On Debt In Year Four
PaymentOfPrincipalAndInterestOnDebtInYearFour
8405000
CY2016Q4 apvo Payment Of Principal And Interest On Debt In Year Five
PaymentOfPrincipalAndInterestOnDebtInYearFive
671000
CY2016Q4 apvo Payment Of Principal And Interest On Debt
PaymentOfPrincipalAndInterestOnDebt
24657000
CY2016Q3 apvo Credit Agreement Exit Fee Percentage
CreditAgreementExitFeePercentage
0.0575
CY2016Q3 apvo Credit Agreement Prepayment Fee Percentage For First Year
CreditAgreementPrepaymentFeePercentageForFirstYear
0.04
CY2016 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000
CY2015 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1664000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1620000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1644000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
554000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5482000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-29000
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-660000
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
15817000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15340000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
97197000
CY2016Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
71013000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
71013000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-86565000
us-gaap Operating Income Loss
OperatingIncomeLoss
-112392000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-87058000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-112809000
CY2016Q1 us-gaap Goodwill
Goodwill
29213000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15317000
CY2016Q4 apvo Federal Net Operating Loss
FederalNetOperatingLoss
20700000
CY2015Q4 apvo Federal Net Operating Loss
FederalNetOperatingLoss
257400000
CY2016Q4 apvo State Tax Losses
StateTaxLosses
10500000
CY2015Q4 apvo State Tax Losses
StateTaxLosses
0
CY2016 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
400000
CY2015 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
13200000
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-83300000
CY2016 apvo Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
76000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
76000
CY2016 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-44714000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-21467000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1189000
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
419000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-29000
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1828000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9549000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
20563000
CY2016 apvo Income Tax Reconciliation Separation Related Adjustment
IncomeTaxReconciliationSeparationRelatedAdjustment
11055000
CY2016 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
460000
CY2015 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3898000
CY2016 apvo Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
10372000
CY2015 apvo Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
535000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
41800000
CY2016Q2 us-gaap Goodwill
Goodwill
29213000
CY2016Q1 us-gaap Assets
Assets
127916000
CY2016Q2 us-gaap Assets
Assets
133470000
CY2016Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
15817000
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
15817000
CY2016Q1 us-gaap Liabilities
Liabilities
38054000
CY2016Q2 us-gaap Liabilities
Liabilities
36273000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
89862000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-71741000
us-gaap Net Income Loss
NetIncomeLoss
-97469000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
8067000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
10193000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
9405000
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
8769000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12982000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12845000
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-14553000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12902000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12849000
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14946000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.63
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.55
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-12890000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-12838000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11000
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
11663000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
7090000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
6562000
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
8286000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11102000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18310000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13188000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-18500000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11397000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18328000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13104000
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18508000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-375000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-612000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-424000
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-610000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-11022000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-17716000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-12680000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-17898000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.88
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.63
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.88

Files In Submission

Name View Source Status
0001564590-17-005738-index-headers.html Edgar Link pending
0001564590-17-005738-index.html Edgar Link pending
0001564590-17-005738.txt Edgar Link pending
0001564590-17-005738-xbrl.zip Edgar Link pending
apvo-10k_20161231.htm Edgar Link pending
apvo-20161231.xml Edgar Link completed
apvo-20161231.xsd Edgar Link pending
apvo-20161231_cal.xml Edgar Link unprocessable
apvo-20161231_def.xml Edgar Link unprocessable
apvo-20161231_lab.xml Edgar Link unprocessable
apvo-20161231_pre.xml Edgar Link unprocessable
apvo-ex231_442.htm Edgar Link pending
apvo-ex311_441.htm Edgar Link pending
apvo-ex312_440.htm Edgar Link pending
apvo-ex321_439.htm Edgar Link pending
apvo-ex322_438.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2017033113331338356260.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending